Global  

Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials

IndiaTimes Monday, 29 June 2020 ()
0
shares
ShareTweetSavePostSend
 
Video credit: Oneindia - Published
News video: India bans 59 Chinese apps, PM Modi's address today and more news| Oneindia News

India bans 59 Chinese apps, PM Modi's address today and more news| Oneindia News 03:15

PM Narendra Modi will address the nation at 4 pm today, his 6th address to the nation since the outbreak of the pandemic; China is set to lose millions of app users in a growing, valuable Indian market; Rahul Gandhi takes dig at BJP, says 'Make in India = Buy from China; Indian and Chinese Corps...

Related videos from verified sources

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine [Video]

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine..

Credit: Wochit     Duration: 00:32Published

Related news from verified sources

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
Mid-Day

India's first COVID-19 vaccine candidate cleared for human trials

Drug Controller General of India approves Bharat Biotech's Covaxin for clinical human trials which will start in July.
Al Jazeera


Tweets about this